NFE2L2 and colorectal carcinoma: To further identify the role of Nrf2 in Ibrutinib regulated the sensitivity of CRC cells to RSL3 or Erastin induction, we knocked out Nrf2 in HT-29 cells by specific shRNA (Nrf2-KO group).